Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action

scientific article published on 7 July 2011

Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11095-011-0524-4
P698PubMed publication ID21735335

P2093author name stringYing Zhang
Kris Hansen
Ken Brown
Kris Siebenaler
Amy Determan
Daniel Dohmeier
P2860cites workDermal and underlying tissue pharmacokinetics of lidocaine after topical application.Q51631818
Topical glyceryl trinitrate and eutectic mixture of local anaesthetics in children. A randomised controlled trial on choice of site and ease of venous cannulation.Q51704698
Adjunctive use of hyaluronidase in local anaesthesia.Q51802278
Pain-free venepuncture. Effect of timing of application of local anaesthetic cream.Q51838455
Factors affecting plasma levels of lignocaine and prilocaineQ52733036
Lidocaine toxicityQ28369125
NMR characterisation and transdermal drug delivery potential of microemulsion systemsQ30620441
Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humansQ30790387
Topical anesthetics update: EMLA and beyondQ30814366
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skinQ33805053
Transdermal drug deliveryQ37238479
Current status and future prospects of transdermal drug delivery.Q40918936
Microneedle pretreatment improves efficacy of cutaneous topical anesthesiaQ43160498
Dermal pharmacokinetics of microemulsion formulations determined by in vivo microdialysisQ43665634
Transdermal delivery of desmopressin using a coated microneedle array patch systemQ44948638
Microneedle mediated delivery of nanoparticles into human skin.Q47331967
Influence of volume on the spread of local anesthetic-methylene blue solution after injection for intercostal blockQ50790290
Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds.Q51631813
P433issue1
P921main subjectlidocaineQ216935
P304page(s)170-177
P577publication date2011-07-07
P1433published inPharmaceutical ResearchQ7180737
P1476titleDevelopment of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action
P478volume29

Reverse relations

cites work (P2860)
Q86952621A drug-laden elastomer for surgical treatment of anal fistula
Q36490572A facile system to evaluate in vitro drug release from dissolving microneedle arrays
Q35778613A simple and high-resolution HPLC-PDA method for simultaneous quantification of local anesthetics in in vitro buccal permeation enhancement studies.
Q47255436Accelerating Topical Anaesthesia Using Microneedles
Q51830991Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents.
Q39162365Analgesic Microneedle Patch for Neuropathic Pain Therapy.
Q38630763Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.
Q36196224Bleomycin-Coated Microneedles for Treatment of Warts
Q35219316Coating solid dispersions on microneedles via a molten dip-coating method: development and in vitro evaluation for transdermal delivery of a water-insoluble drug
Q38860500Considerations in the use of microneedles: pain, convenience, anxiety and safety
Q37468550Controlled Drug Delivery Using Microdevices
Q91778005Design rules for a tunable merged-tip microneedle
Q47995144Dissolving microneedles to obtain rapid local anesthetic effect of lidocaine at skin tissue
Q47344337Drug-coated microneedles for rapid and painless local anesthesia
Q90318630Effect of dosing regimen and microneedle pretreatment on in vitro skin retention of topically applied beta-blockers
Q47977602Effects of eight vehicles on transdermal lidocaine penetration in sheep skin in vitro
Q47569582Efficacy of a bleomycin microneedle patch for the treatment of warts
Q41518982Enhanced delivery of hydrophilic peptides in vitro by transdermal microneedle pretreatment
Q57291851In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions
Q89287740Individually coated microneedles for co-delivery of multiple compounds with different properties
Q45760750Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs
Q47290157Large Size Microneedle Patch to Deliver Lidocaine through Skin.
Q47717700Lidocaine permeation from a lidocaine NaCMC/gel microgel formulation in microneedle-pierced skin: vertical (depth averaged) and horizontal permeation profiles
Q47629261Local, Controlled Delivery of Local Anesthetics In Vivo from Polymer - Xerogel Composites
Q38105616Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications
Q41006286Microfabrication for Drug Delivery
Q38646712Microneedle patches for vaccination in developing countries.
Q30575700Microneedle patches: usability and acceptability for self-vaccination against influenza
Q38680038Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use.
Q35563011Microneedle-Mediated Delivery of Copper Peptide Through Skin.
Q47952817Microneedle-assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel
Q28085656Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Q36164749Microneedles for drug and vaccine delivery
Q30472037New delivery systems for local anaesthetics-part 2.
Q38122744Novel engineered systems for oral, mucosal and transdermal drug delivery.
Q38108243Potential of biodegradable microneedles as a transdermal delivery vehicle for lidocaine
Q47666014Recent advances of controlled drug delivery using microfluidic platforms.
Q64892919Recent advances of microneedles for biomedical applications: drug delivery and beyond.
Q33832173The effects of chemical and physical penetration enhancers on the percutaneous permeation of lidocaine through equine skin
Q26778469Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum

Search more.